Mr. Aldrich is a specialist in the commercialization of products. He has held executive level positions for the last ten years. His experience includes Apple, Silicon Graphics, two successful start-ups and a role as managing director of a regional venture capital firm. He has lectured extensively and has volunteered at UCSD in the Connect program. He has been involved in technology transfer at the UW.

Mr. Reed is a Ph.D. chemist with 17 years of experience in the development of biotech products. His expertise is in linking biological active molecules (antibodies, DNA probes, therapeutics) to other signal molecules or surfaces. He has a strong background in R&D management, technology presentation (over 50 published papers), and intellectual property (twelve issued U.S. patents).

Ms. Matuizek held key roles in Quality Control and Manufacturing at Genetic Systems and made significant contributions to bring the first HIV in vitro diagnostic device to market. In 2009 Donna joined the Scientific Advisory Board for Immusoft Corporation, a private venture advancing new technologies in cell therapy.

Mr. Geelhood has a Masters of Science in Chemical Engineering from the University of Washington where he worked with biomaterials and the interactions of proteins and cells on surfaces. He has over five (5) years of experience in the medical device industry, leading the engineering development of the pH SAFE Reader (formerly pH1000).

Mr. Gestwick is a mechanical engineer with a Masters of Engineering Management from the Thayer School of Engineering at Dartmouth College. His professional experience has spanned multiple industries with companies such as GE, Z Corporation and K2.